ORGANIZATION - Pharma Japan -

Tuesday, July.17.2018

Remember Me

Home＞ORGANIZATION

New JPMA Chief Calls for Scrapping PMP Company Criteria
June 1.2018
Sawai President Elected New Generic Industry Chief
May 30.2018
Drug Damage Watchdog Submits Opinion to Health Ministry, Opposing Current Conditional Early Approval System
May 30.2018
Big Data Analysis Finds Low Generic Drug Use Rate among Healthcare Professionals: Kyokai Kenpo
May 28.2018
Daiichi Sankyo CEO Nakayama Appointed as New President of JPMA
May 25.2018
Isao Teshirogi Elected New FPMAJ Chairman
May 25.2018
PhRMA Vision Report Stresses Innovation as Investment for Healthier Lifespans
May 17.2018
Over 80% Concerned about Restrictions on Access to Prescription Drugs: PhRMA Survey
May 15.2018
Drug Damage Watchdog Calls for 3rd Party Long-Term Investigation for HPV
May 2.2018
PhRMA/EFPIA Deeply Concerned about MOF Pitch on Stringent CEA Application
April 26.2018

＜ Prev 1 2 3 4 5 6 7 8 9 10 Next ＞

Astellas/Daiichi Sankyo Showdown Looms as Their FLT3 Inhibitors Near Approval

G1/G2 Rule：
G1/G2ルール

5 Billion Yen Blockbuster?

Lilly Japan Marks Opening of New Kobe Headquarters(Jul.17)

Boehringer’s DPP-4/SGLT2 Combo Up for MHLW Panel Review on July 27(Jul.17)

Taiho Exercises Option to Gain Asian Rights to Arcus’ I/O Candidate(Jul.17)

Takeda Jettisons Japan Rights to Obesity Drug OBLEAN after Long Listing Limbo(Jul.17)

MHLW to Introduce Guidelines for Sales Reps’ Activities, Calling for the Creation of Supervising Offices(Jul.17)

1.: MHLW Approves Entyvio, Imfinzi, Lynparza...
2.: New Takeda Global Headquarters Designed ...
3.: MHLW Official Expounds on “Authorized Bi...
4.: As Biosimilars Show Mixed Performances, ...
5.: MHLW Orders Removal of Pregnancy Contrai...